Vext Science, Inc. (CSE:VEXT)
Canada · Delayed Price · Currency is CAD | Market Cap | 64.40M +100.1% |
| Revenue (ttm) | 72.54M +32.7% |
| Net Income | -21.71M |
| EPS | -0.09 |
| Shares Out | 247.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,000 |
| Open | 0.2550 |
| Previous Close | 0.2600 |
| Day's Range | 0.2500 - 0.2600 |
| 52-Week Range | 0.1100 - 0.4000 |
| Beta | 0.77 |
| Analysts | Strong Buy |
| Price Target | 0.95 (+280.0%) |
| Earnings Date | Aug 20, 2026 |
About Vext Science
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brand... [Read more]
Financial Performance
In 2025, Vext Science's revenue was $51.37 million, an increase of 42.69% compared to the previous year's $36.00 million. Losses were -$17.99 million, -19.79% less than in 2024.
Financial numbers in USD Financial StatementsNews
Vext Opens Sixth Ohio Dispensary in Fairfield
A high-visibility location on one of the area's busiest retail corridors, anchored by neighboring Jungle Jim's International Market - expected to drive durable store-level performance. Vancouver, Brit...
Vext Science Earnings Call Transcript: Q1 2026
Revenue rose 5% year-over-year to $12.2M, led by Ohio's 34% growth, while Arizona declined 24% amid wholesale compression. Gross profit more than doubled, adjusted EBITDA margin improved to 29%, and net loss narrowed to $0.9M. Ohio retail expansion and Arizona streamlining remain key priorities.
Vext Science Earnings release: Q1 2026
Vext Science released its Q1 2026 earnings on May 21, 2026, summarizing the period's financial results.
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million. Operating cash flow of $1.6 million and ...
Vext Engages Zuanic & Associates
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and Ohi...
Vext Announces Date for Q1 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announc...
Vext Science Slides: Investor presentation
Vext Science has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Vext Science Earnings Call Transcript: Q4 2025
Revenue grew 43% year-over-year to $51.4M, with operating cash flow up 256% to $11.7M, driven by Ohio retail expansion. Arizona operations shifted to a retail-first model, exiting cultivation to optimize margins. DEA reclassification could materially reduce tax liabilities.
Vext Science Earnings release: Q4 2025
Vext Science released its Q4 2025 earnings on April 29, 2026, summarizing the period's financial results.
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million...
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today annou...
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equi...
Vext Advances Ohio Expansion with Seventh Retail Location
Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals. Marks Vext's seventh dispensary in Ohio, and second in Colu...
Vext Announces Voting Results of Annual General Meeting
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations in ...
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in ...
Vext Science Earnings Call Transcript: Q3 2025
Q3 2025 saw 41% year-over-year revenue growth to $12.7M, driven by Ohio retail expansion and resilient Arizona operations. Margins were pressured by Arizona price declines, but positive cash flow and improved cultivation yields position the company for a strong Q4 and continued growth into 2026.
Vext Science Earnings release: Q3 2025
Vext Science released its Q3 2025 earnings on November 20, 2025, summarizing the period's financial results.
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations and continued resilient performance in Arizona. YTD operating cash flow of $8.5 million compared to $(0.7) million in Q3...
Vext to Announce Financial Results for Q3 2025 on November 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in...
Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer
Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and ear...
Vext Science Earnings Call Transcript: Q2 2025
Q2 2025 saw 59% revenue growth and a 30% adjusted EBITDA margin, driven by rapid Ohio retail expansion and disciplined Arizona operations. Free cash flow and operating leverage improved, with a focus on scaling Ohio and maintaining profitability in a challenging Arizona market.
Vext Science Earnings release: Q2 2025
Vext Science released its Q2 2025 earnings on August 20, 2025, summarizing the period's financial results.
Vext Science Slides: Q2 2025
Vext Science has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 20, 2025.
Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin
Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona. Revenue of $13.4 million, up 59% Yo...
Vext to Announce Financial Results for Q2 2025 on August 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in A...